Sing George L's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Aug 13, 2021
- Accession no.
- 0001237899-21-000014
- Filed
- Aug 13, 2021
- Trade date
- Aug 11-13, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $2.35M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sing George LCIK 0001225471 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2021 | Common Stock | SSaleDisposed | −1,000 | $620.00 | −$620,000 | 47,063 | Direct | |
| Aug 11, 2021 | Common Stock | SSaleDisposed | −1,000 | $621.00 | −$621,000 | 46,063 | Direct | |
| Aug 12, 2021 | Common Stock | SSaleDisposed | −1,000 | $611.00 | −$611,000 | 45,063 | Direct | |
| Aug 13, 2021 | Common Stock | SSaleDisposed | −500 | $620.00 | −$310,000 | 44,563 | Direct | |
| Aug 11, 2021 | Common Stock | SSaleDisposed | −300 | $620.00 | −$186,000 | 3,050 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.